Načítá se...
Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial
INTRODUCTION: The aim of this study was to collect data in France in patients with heparin-induced thrombocytopenia who required parenteral anticoagulation and for whom other non-heparin anticoagulant therapies were contraindicated including patients with renal failure, cross-reactivity to danaparoi...
Uloženo v:
| Vydáno v: | Crit Care |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4641392/ https://ncbi.nlm.nih.gov/pubmed/26556106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-1109-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|